Chemotherapy of premalignant lesions: new insights.
Ravery
Vincent
V
University Hospital Bichat, Paris, France. vincent.ravery@bch.ap-hop-paris.fr
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D051379:Mice; D011230:Precancerous Conditions / Q000188:drug therapy* / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood; D019048:Prostatic Intraepithelial Neoplasia / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D012307:Risk Factors
D018931:Antineoplastic Agents, Hormonal; D000975:Antioxidants; D017430:Prostate-Specific Antigen